Search Abstracts Program

Session 43   Poster Session Neutralizing Antibodies 4:30-6:30 pm 4E-F

240-T.	Cross-Clade Neutralization of HIV-1 Primary Isolates by Human Monoclonal Antibodies that Recognize Conformational V3 Epitopes M. K. Gorny*1, C. Williams1, B. Volsky1, K. Revesz2, S. Cohen1, V. Polonis3, W. J. Honnen4, C. Krachmarov4, A. Pinter4, and S. Zolla-Pazner1 1New York Univ. Sch. of Med., New York; 2Veterans Affairs Med. Ctr., New York, NY; 3U.S. Military HIV Res. Prgm., Rockville, MD; and 4Publ. Hlth. Res. Inst., New York, NY Add to Itinerary
241-T.	Cross-Clade Neutralization of Human Immunodeficiency Virus-1 Primary Isolates by Anti-CCR5 Antibodies Present in Long-Term Non-Progressors C. Barassi1, C. Pastori1, S. Ghezzi1, G. Poli1, M. Clerici2, A. Lazzarin2, and L. Lopalco*1 1San Raffaele Sci. Inst. and 2Univ. of Milano, Italy Add to Itinerary
242-T.	B2.1, A Peptide that Specifically Binds the Broadly HIV-1-Neutralizing, Human Antibody, b12 A. Menendez*1, M. Zwick1, M. Montero1, N. van Houten1, M. Irving1, L. Bonnycastle1, C. Barbas III2, P. Parren2, D. R. Burton2, and J. Scott1 1Simon Fraser Univ., Burnaby, BC, Canada and 2 Scripps Res. Inst., La Jolla, CA Add to Itinerary
243-T.	The Role of Patient Virus Properties and Neutralizing Antibody Responses in Structured Treatment Interruption Therapy A. Trkola*1, H. Kuster1, C. Ruprecht1, C. Leemann1, P. Rusert1, R. Weber1 , B. Hirschel2, and H. Gunthard1 for the Swiss HIV Cohort Study 1Univ. Hosp., Zurich; and 2Univ. Hosp., Geneva, Switzerland Add to Itinerary

---